Novo Nordisk

13 Stories

Novo Nordisk's Insulin Change Attracts Critics

Company is no longer making pens containing human insulin

(Newser) - As a teen, Lecritia Roberts injected herself with insulin using a glass vial and a syringe to manage her type 1 diabetes, and not without struggle. The 31-year-old South African woman tells the Guardian the glass vials the insulin came in had some downsides, among them less precision and the...

Ozempic May 'Slow Down the Aging Process'
Ozempic May 'Slow Down
the Aging Process'
NEW STUDY

Ozempic May 'Slow Down the Aging Process'

Studies suggest drug reduces risk of death from all causes, as well as inflammation

(Newser) - Semaglutide, the active ingredient of Ozempic and Wegovy, has been painted as a miracle weight-loss drug, with evidence suggesting it also reduces risk of death and serious illness in people with diabetes and kidney disease. Now, a series of studies indicate semaglutide might do more than that. The drug "...

Weight Loss Drug Might Also Help Your Brain

Daily liraglutide injections linked to slower cognitive decline in Alzheimer's patients

(Newser) - A drug similar to Ozempic, used to treat diabetes and obesity, might also be used to treat and slow the progression of Alzheimer's disease, according to a small study. Researchers from Imperial College London observed 204 Alzheimer's patients in the UK over a year. Half were given daily...

Sanders: Why Does Ozempic Cost 10 Times More in US?

Drugmaker's boss agrees to appear at Senate hearing

(Newser) - Lars Fruergaard Jørgensen, the chief executive of Novo Nordisk, agreed in a phone call with Sen. Bernie Sanders to testify before a Senate committee in September. He already knows what Sanders will ask: why Ozempic and Wegovy cost "10 to 15 times" more in the US than in...

This Ozempic Study Went So Well That It Was Stopped Early

Research finds semaglutide can cut risk of serious illness, death in those with diabetes, kidney disease

(Newser) - Semaglutide , the medication found in such brands as Ozempic and Wegovy, has become the drug of choice lately for weight loss. A new study, however, suggests it can also bring other significant benefits to users, including slashing the risk of serious kidney complications, heart problems, and even death in...

Weight-Loss Drug May Cut Heart Risks, Too
Study May Change Coverage
for Weight-Loss Drugs
new study

Study May Change Coverage for Weight-Loss Drugs

Maker of Wegovy cites heart benefits, which could pressure insurers to start covering

(Newser) - A new study suggests the popular weight-loss drug Wegovy might cut the risk of heart disease as well. If the study is confirmed—and it hasn't yet been peer-reviewed—the results could pressure insurers to start covering the pricey drug, reports the New York Times . Maker Novo Nordisk charges...

Injectable Weight-Loss Drug May Soon Come in Pill Form
Injectable Weight-Loss Drug
May Soon Come in Pill Form
NEW STUDIES

Injectable Weight-Loss Drug May Soon Come in Pill Form

Novo Nordisk wants FDA to OK pills that use same medication used in Wegovy, Ozempic

(Newser) - What if treating obesity could be as easy as popping an effective pill? That's a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese—and fueled criticism by those who advocate for wider weight acceptance. Soon, it may be...

Another Drugmaker Joins Insulin Price Cuts

Novo Nordisk joins Eli Lilly, with new pricing set to go into effect Jan. 1

(Newser) - Novo Nordisk will start slashing some US insulin prices up to 75% next year, reports the AP , following a path set earlier this month by rival Eli Lilly . The Danish drugmaker said Tuesday that prefilled pens and vials of long- and short-acting insulins will see list price reductions. They include...

Walmart Touts a Revolution in Diabetes Care

Retailer to offer low-cost analog insulin starting this week

(Newser) - Walmart says diabetes patients can save up to 75% on rapid-acting insulin by purchasing its own brand of the drug, launching this week. What it calls the "first-ever private brand analog insulin"—to be sold at Walmart pharmacies this week and at Sam's Club pharmacies in mid-July—...

Yet Another Big Blow for Paula Deen

 3 More Big Blows 
 for Paula Deen 
UPDATED

3 More Big Blows for Paula Deen

Sayonara Novo Nordisk, Target, Home Depot

(Newser) - As Paula Deen was dropped by seemingly every company she's ever been associated with, Novo Nordisk continued to say it would stand by her—but even that relationship appears to have frayed. The diabetes drug maker that partnered with Deen as she announced she had the disease today announced...

Paula Deen Sugar-Coats Reality of Diabetes

Celebrity chef's 'moderation' diet doesn't cut it: Karen Stabiner

(Newser) - Celebrity chef Paula Deen has gone from celebrating fatty and fried foods to admitting last week she's a closet diabetic . The kicker: She's now promoting a $500-a-month diabetes drug with the slogan, "Live a life that's delicious." Feeling queasy yet? "Deen got handed a...

Deen Makes Unfortunate Declaration About Life

Her 6-word memoir would read ... 'Might as Well Eat That Cookie'

(Newser) - Paula Deen, that bastion of moderation and recent convert to the church of Novo Nordisk after her not-so-recent diagnosis of type 2 diabetes , has a memoir out. Well, an Oprah-version of a memoir. Winfrey's magazine asks various celebs and non-celebs to succinctly sum up their lives in a "...

Paula Deen Confirms Type 2 Diabetes, Partners With Drugmaker Novartis
Deen Confirms Diabetes, Partners With Drugmaker
UPDATED

Deen Confirms Diabetes, Partners With Drugmaker

Paula wants to show American public 'simple ways' to cope with disease

(Newser) - It's as official as it is unshocking: Butter-slinging celeb chef Paula Deen—she who combined a Krispy Kreme doughnut, hamburger, bacon, and fried egg and called it breakfast —confirms that she has Type 2 diabetes . But she's determined to make something positive out of the diagnosis, like...

13 Stories